Ansell Limited and CSL Limited: 2 growth companies for long-term investors

Long-term strong performers CSL Limited (ASX:CSL) and Ansell Limited (ASX:ANN) could also work in an income portfolio.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This month's reporting season has revealed a number of great companies that raised earnings even in an economy still not firing on all cylinders.

Two of those companies need to get special recognition because they are solid performers that keep pushing to improve business and raise earnings. As income stocks in your portfolio, they could work to help create future wealth.

Ansell Limited (ASX: ANN) is a market leader for protective wear, such as plastic and fabric gloves found in many hospitals and warehouses, as well as condoms in your local supermarkets and pharmacies.

Both earnings and book value per share have doubled in the past ten years. In FY 2014, underlying net profit gained 13% on a 16% rise in revenue. It has a 2.0% dividend yield unfranked. Analyst consensus forecasts are for earnings to rise an average 10% per year over the next two years.

Just like Gillette razors, each product may not be very expensive, but the sheer amounts that are used on a daily basis make it a very attractive kind of business for long-term investors.

CSL Limited (ASX: CSL), the largest biopharmaceutical company listed on the S&P/ASX 200 Index (ASX: XJO) (Index: ^XJO), produces vital medical products for viral and bacterial diseases as well as blood disorders. The company benefits from high demand for its specialised products and can charge a premium for them.

In its recent FY 2014 full year results, net profit was up 8%. Just as important, the final dividend was raised 15% to US 60 cents per share for a full year dividend of US$1.13 cps. Currently, its yield is 1.7% unfranked.

Over the past 10 years, dividends have risen about six times, which should have made its shareholders very happy and a little richer. Going forward, a strong healthcare stock like CSL in your portfolio could give you the dividend income you are looking for in the long term.

Motley Fool contributor Darryl Daté-Shappard does not own shares in any company mentioned. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »